EMA grants AZ’s Vaxzevria COVID-19 vaccine full marketing authorisation

Previously, Vaxzevria was given a conditional Marketing Authorisation (cMA) due to the critical nature of the COVID-19 pandemic, and as further significant evidence of safety and efficacy benefits of Vaxzevria

GSK’s application for its RSV vaccine accepted by EMA under accelerated assessment

marketing authorisation (CMA) in the EU.

Novartis bags CHMP recommendation for prostate cancer drug Pluvicto

Novartis’ Pluvicto (INN: lutetium (177Lu) vipivotide tetraxetan) has been recommended for conditional marketing authorisation (CMA) in the EU for the treatment of adult patients with progressive prostate-specific membrane antigen

BeiGene’s Brukinsa receives CHMP recommendation for chronic lymphocytic leukaemia

CLL accounts for around one-quarter of new leukaemia cases. BeiGene’s Brukinsa (zanubrutinib) has been recommended for conditional marketing authorisation (CMA) by the European Medicines Agency’s (EMA) Committee for

AstraZeneca/Sanofi’s Beyfortus receives CHMP recommendation for prevention of RSV disease in infants

AstraZeneca (AZ) and Sanofi’s Beyfortus (nirsevimab) has been recommended for conditional marketing authorisation (CMA) in the EU for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in

Strengthening business competition and reducing anti-competitive practices

A firm pharma focus. The CMA’s focus on the pharmaceutical industry is not surprising. ... cartel activities and serious abuses of a dominant position, which the CMA categorises.

Five things you didn't realise you already know about influencer marketing

The Advertising Standards Authority (ASA) and Competitions and Markets Authority (CMA) have been applying stricter guidelines and monitoring the industry more closely. ... Always seek advice from the agency you’re working with or directly from the ASA

Stakeholder dialogue in Europe’s adaptive pathways pilot

The use of real-world evidence (RWE) as a complement to clinical trial data to support reimbursement decisions after Conditional Marketing Authorisation (CMA) is granted.

Drug pricing

Healthcare systems